About AxoSim
AxoSim is a company based in New Orleans (United States) founded in 2014. AxoSim has raised $6.78 million across 11 funding rounds from investors including NIH, TPG and HHS. The company has 27 employees. AxoSim offers products and services including AxoSim Platform and Products. AxoSim operates in a competitive market with competitors including Emulate, CN Bio, Mimetas, Nortis and NETRI, among others.
- Total Equity Funding$6.78M (USD)
in 11 rounds
- Latest Funding Round$3.68M (USD), Series A
Nov 2024
- InvestorsNIH
& 6 more
- Employee Count27
Products & Services of AxoSim
AxoSim offers a comprehensive portfolio of products and services, including AxoSim Platform and Products.
Tool for building and studying human brain models in labs.
Resources for addressing neurological disorders through lab innovation.
Funding Insights of AxoSim
AxoSim has successfully raised a total of $6.78M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $3.68 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.78M
- Total Rounds 11
- Last Round Series A — $3.68M
- First Round $299,226
(Feb 2016)
- Investors Count 7
Latest 10 of 11 funding rounds of AxoSim with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $3.68M | Series A | – | – | – |
| Sep 2020 | $227,946 | Grant | – | – | |
| Jun 2020 | $1.97M | Seed | – | Benson Capital Partners | |
| Aug 2019 | $646,977 | Grant | – | – | |
| Mar 2019 | $1.13M | Seed | – | – | – |
| Sep 2018 | $197,625 | Grant | – | – | |
| Apr 2018 | $100,000 | Grant | – | – | |
| Sep 2017 | $1.7M | Grant | – | – | |
| Jul 2016 | $225,000 | Grant | – | – | |
| Mar 2016 | $225,000 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in AxoSim
AxoSim has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, TPG and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Jefferson Capital Partners is engaged in providing growth capital solutions. | 2002 | jeffcap.com | Mandeville, United States | |
A 4-month acceleration program for technology startups is provided. | 2000 | ideavillage.org | New Orleans, United States | |
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
- | – | sbir.nih.gov | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
- | – | bensoncp.com | - | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for AxoSim
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AxoSim
6 people are tracked at AxoSim (1 in leadership, 5 in board & advisors); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Gregory Kading | Consulting CFO | Leadership |
Mike Katz | Board Member | Board & advisors |
Joe Truhe | Board Member | Board & advisors |
David Weiner | Board Member | Board & advisors |
Jules Selkirk | Board Member | Board & advisors |
Pat Dougherty | Board Member | Board & advisors |
Complete people profiles for AxoSim
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AxoSim
3 dated milestones of AxoSim across 10 years, from founding to its latest funding, stage changes and deals.
- Founded AxoSim is founded.
- Funding First funding round of $299K.
- Funding Latest funding round, Series A, of $3.7M.
Competitors of AxoSim
AxoSim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, Mimetas, Nortis and NETRI, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| cellboxlabs.com | 2020 | Riga, Latvia | $1.01M | 10 | Organ-on-chip platform is provided for drug discovery and development. | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. |
Detailed competitors of AxoSim
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axosim
Complete news archive for AxoSim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AxoSim
10 companies that operate in the same segment as AxoSim (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AxoSim
AxoSim was founded in 2014 and raised its 1st funding round 2 years after it was founded.
AxoSim is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
AxoSim is a funded company, having raised a total of $6.78M across 11 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Feb 2016.
AxoSim has 27 employees.
AxoSim was founded in 2014 in New Orleans, United States, with a focus on biotechnology. Nerve-on-a-chip technology, a 3D cell-based model mimicking nerve functions, was developed in Dr. Michael J. Moores lab at Tulane University. Funding has been received from the National Science Foundations Innovation Corps program. Operations center on creating these models to support drug testing and development processes in the biotech sector.
AxoSim's top competitors include Emulate, CN Bio and Cellbox Labs.
AxoSim offers AxoSim Platform and Products.
AxoSim has 7 investors. Key investors include NIH, TPG, HHS, The Idea Village, and Benson Capital Partners.
AxoSim operates through Axosim, Inc..